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There are now five studies, including the report of Akil and co-
workers in this issue of the Br J Cancer, for which the relationship
between age of women and high-risk human papilloma virus
(HPV)-positive breast cancer, has been published. Three of these
studies report that the age of women with HPV-positive breast
cancer is significantly younger than the women with HPV-negative
breast cancer. On an average, Greek women with HPV-positive
breast cancer were 15 years, Australian women 8 years, and
Canadian and Syrian women were 11 years younger than those
with HPV-negative breast cancer (Kroupis et al, 2006; Lawson
et al, 2006; Akil et al, 2007). Two studies report no difference in the
age of women with HPV-positive or -negative breast cancer
(Hennig et al, 1999; Damin et al, 2004). Some details of these
studies are shown in Table 1.
Based on the younger age of some women with HPV-positive
breast cancer, and the higher incidence of HPV-positive cervical
cancer among younger women with multiple sexual partners, we
have hypothesised that high-risk HPVs may be transmitted to the
breast during sexual activities (Lawson et al, 2006).
The underlying assumption to these observations and hypo-
theses is that high-risk HPVs may have a causal role in some breast
cancers. Therefore, a brief overview of the relevant evidence is of
value.
The presence of high-risk HPV DNA in breast tumours has been
shown, mainly by PCR analyses, in 11 out of 13 studies conducted
in a various countries (reviewed by Lawson et al, 2006; plus a
recent positive study by Yasmeen et al, 2007; a negative study by
Lindel et al, 2007). Tumours of the breast nipple appear to have
histological characteristics similar to HPV-positive cervical cancer
(de Villiers et al, 2005).
Similar high-risk HPVs have been identified in breast tumours
and cervical cancer that have occurred in the same women (Hennig
et al, 1999; Widschwendter et al, 2004).
There is immortalisation and preneoplastic transformation of
normal breast epithelial cells by HPVs (Band, 1995).
High-risk HPVs, in particular HPV types 16, 18, 31, 33 and less
commonly additional types, are the accepted cause of cervical and
other ano-genital cancers (IARC, 1995). Less well known is the
likely causal role of high-risk HPVs in cancers of the head and
neck (van Houten et al, 2001). The biological mechanisms by
which HPVs are tropic and oncogenic to epithelial cells is
reasonably well known from studies of cervical oncogenesis. These
mechanisms include the presence and genomic integration of HPV
DNA in epithelial tumours, the expression of the HPV E6 oncogene
in the tumour where it binds to and degenerates the tumour
suppressor p53 gene allowing unregulated cell proliferation to
occur (zur Hausen, 2002). Hormones play a central role on HPV
oncogenesis. Estrogens synergise with HPV oncogenes to cause
cervical cancer (Brake and Lambert, 2005) and the regulatory
region of HPV 16 contains DNA sequences that are responsive to
glucocorticoid hormones (Gloss et al, 1987).
Because of the presumably low viral load, PCR analyses for HPV
on both formalin-fixed and fresh-frozen breast tumour specimens
are difficult and very dependent on the details of the methods
used. For example, the negative outcomes by Lindel et al (2007)
have probably been because they used the incorrect PCR primers
(Damin et al, 2007; Yasmeen et al, 2007). In our own studies, the
identification of HPV DNA proved to be difficult and required
additional amplification of the DNA before PCR and the use of
SYBR Green I to optimise detection (Kan et al, 2005).
Table 1 Average age of women with HPV-positive and HPV-negative breast cancer
Study Population HPV type Age HPV + Age HPV–
P-Value for age
difference
Hennig et al, 1999; n¼107 Norway 16 50.8 49.4 0.659, NS
Damin et al, 2004; n¼101 Brazil 16/18 56.5 55.9 0.806, NS
Kroupis et al, 2006; n¼107 Greece 16 38 55 0.001, S
Lawson et al, 2006; n¼50 Australia 18 55.6 63.8 0.049, S
Akil et al, 2007 Canada/Syria 16 46.5 57.5 0.05, S
NS¼not significant; S¼significant at 95% level.
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www.bjcancer.comThe main means of transmission of HPVs appears to be by surface
contact. The human papilloma virions are released when the cornified
envelope of cells desquamate (Bryan and Brown, 2001). The
possibility of transmission of high-risk HPVs during sexual activity
is demonstrated by the high prevalence of these viruses in male and
female genital organs. The prevalence of high-risk HPVs in male
genital organs varies by population and methods of detection. The
prevalence of high-risk HPVs in the penile glans, penile shaft, prepuce
and scrotum is between 5 and 50%, the perianal area 0–33%, semen
2–8 3 %a n du r i n eu pt o7 %( D u n n eet al, 2006). High-risk HPVs are
also present in normal, benign hyperplastic and malignant prostate
tissues (Zambrano et al, 2002). The prevalence of high-risk HPVs in
females varies between populations and dramatically so between age
groups, with the prevalence in near normal cervical smears from UK
women 61% at ages 20–24 decreasing to 14–15% in those over 50
years (Cotton et al, 2007).
What meaning might be given to these observations? In our
view, the evidence that high-risk HPVs may have an aetiological
role in human breast cancer is substantial but far from conclusive.
Obviously further work needs to be done.
A working hypothesis is that high-risk HPVs may be involved in
the initiation of breast cancer among younger women.
The Editor now considers correspondence on this publication
closed.
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